T
Tianjin Tianyao Pharmaceuticals Co Ltd
SSE:600488
Tianjin Tianyao Pharmaceuticals Co Ltd
SSE:600488
Price:
3.94
CNY
-0.51%
Market Closed
Market Cap:
¥4.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Tianjin Tianyao Pharmaceuticals Co Ltd
SSE:600488
|
CN |
|
Z
|
Zhejiang Kaier New Materials Co Ltd
SZSE:300234
|
CN |
|
W
|
Wee Hur Holdings Ltd
SGX:E3B
|
SG |
|
Macquarie Group Ltd
ASX:MQG
|
AU |
|
N
|
NSL Foods PCL
SET:NSL
|
TH |
|
E
|
Euwax AG
F:EUX
|
DE |
|
Z
|
Zhuhai Port Co Ltd
SZSE:000507
|
CN |
|
J
|
Jiangyin Hengrun Heavy Industries Co Ltd
SSE:603985
|
CN |
|
Yangzhou Chenhua New Material Co Ltd
SZSE:300610
|
CN |
Multiples-Based Value
The Multiples-Based Value of one Tianjin Tianyao Pharmaceuticals Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 3.94 CNY, Tianjin Tianyao Pharmaceuticals Co Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Tianjin Tianyao Pharmaceuticals Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Tianjin Tianyao Pharmaceuticals Co Ltd Competitors
Tianjin Tianyao Pharmaceuticals Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
T
|
Tianjin Tianyao Pharmaceuticals Co Ltd
SSE:600488
|
4.3B CNY | 1.5 | 264 | 23.7 | 23.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 9.8 | 7.3 | 8.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
